Replies to post #568 on Palatin Technologies Inc. (PTN)

[eicoman]

good point, local vs brain chemistry,

Femprox is more for FSAD, women who have desire but have difficulty with lubrication, orgasm, sensitivity, local arousal, etc..

BMT is more for women with psychological issues of no interest, no sexual thoughts. So there are 2 categories. So yes, BMT could be preferred in that category of no interest but it will not capture the whole FSD market, imo. It's still a sizable market for BMT if they can get results far enough above placebo, which is the Flibaserin problem.

How much more safe or efficacious is BMT compared to Flibaserin, Flibaserin is now limiting their approach to pre-menopausal women , where they had better results in their most recent studies, same with Femprox, femprox is going pre-menopausal in the EU first, since the FDA is so hard to crack.